YLYu-Chih Liu

Yu-Chih Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu-Chih Liu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Amino Acid-Based Metabolic Indexes Identify Patients With Chronic Obstructive Pulmonary Disease And Further Discriminates Patients In Advanced BODE Stages

    by Wei-Ke Kuo, Yu-Chih Liu, Chien-Ming Chu, Chung-Ching Hua, Chih-Yu Huang, Min-Hui Liu, Chao-Hung Wang

    Background: The BODE index is a multidimensional grading system for predicting the prognoses of patients with chronic obstructive pulmonary disease (COPD). This study investigated whether an amino acids-based metabolic profile developed for heart failure patients (including histidine, ornithine, phenylalanine, and leucine) could identify COPD patients and further discriminates COPD patients in advanced BODE stages. Methods: Ultra-performance liquid chromatography was performed on 119 participants, including 75 COPD patients at different BODE stages and 44 normal controls. Albumin, pre-albumin, transferrin, high sensitivity C-reactive protein, and hand grip strength were also measured. Receiver operating characteristic curves and area under curves were used for estimation. Results: The BODE points in our patients were 3.29 [95% confidence interval (CI) = 2.74–3.85]. Compared to normal controls, COPD patients had lower leucine but higher ornithine levels. A COPD score, developed based on leucine and ornithine, significantly discriminated COPD from normal controls [odds ratio (OR) = 2.71, 95% CI = 1.83–4.04, p Conclusion: Amino acid-based COPD score and metabolic score discriminate COPD patients from normal controls, and identify patients in advanced stages of COPD.


  • Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening

    by Yan Ye, Bidong Zhang, Ruifeng Mao, Chenhua Zhang, Yulan Wang, Jing Xing, Yu-Chih Liu, Xiaomin Luo, Hong Ding, Yaxi Yang, et al.

    Protein arginine methyltransferase 5 (PRMT5) is a type II PRMT enzyme critical for diverse cellular processes and different types of cancers. Many efforts have been made to discover novel scaffold PRMT5 inhibitors. Herein, we report the discovery of DC_P33 as a hit compound of PRMT5 inhibitor, identified by molecular docking based virtual screening and 3H-labeled radioactive methylation assays. Structure–activity relationship (SAR) analysis was performed on the analogs of DC_P33 and then structural modifications were done to improve its activity. Among the derivatives, the compound DC_C01 displayed an IC50 value of 2.8 μM, and good selectivity toward PRMT1, EZH2 and DNMT3A. Moreover, DC_C01 exhibited anti-proliferation activities against Z-138, Maver-1, and Jeko-1 cancer cells with EC50 values of 12 μM, 12 μM, and 10.5 μM, respectively. Taken together, these results contribute to the development of specific inhibitors against PRMT5 and cancer therapy.


  • Sales forecasting for thin film transistor liquid crystal display products with data clustering and an evolving neural network model

    by P-C Chang, C-Y Fan, J Y-C Liu, W-H Huang

    There are specific characteristics in the thin film transistor liquid crystal display (TFT-LCD) industry, such as unexpected demand fluctuation, customized products that each customer will designate a specific key component, long lead time of procurement, and short product life cycle. This research presents a genetic algorithm integrated with a neural network model for monthly sales forecasting of TFT-LCD products in Taiwan. The practical situation and its requirements are explained and two systematic approaches are discussed: (a) a K-means clustering for historic sales data and new sales is forecasted by mapping its inputs into one of these clustered data, and (b) a neural network integrated with a genetic algorithm for supervised learning of the functional behaviour of time-series data and their approximation. The evolving neural network model is applied for modelling the system's behaviour with the possibility of exploiting expert information and systematic optimization. The model has been tested and satisfying results are shown with practical data.